Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Treasury Shares (2025 - 2026)

Beta Bionics' Treasury Shares history spans 2 years, with the latest figure at $2.4 million for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 157.23% to $2.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 million, a 157.23% increase, with the full-year FY2025 number at $753885.0, changed N/A from a year prior.
  • Treasury Shares hit $2.4 million in Q1 2026 for Beta Bionics, up from $753885.0 in the prior quarter.
  • Over the last five years, Treasury Shares for BBNX hit a ceiling of $2.4 million in Q1 2026 and a floor of $753885.0 in Q4 2025.